For example, Lee et al.[5] have developed a nomogram to refine prognostication in this group using six pre-treatment variables [TFIp, performance status, size of the largest tumour, cancer antigen-125 (CA-125), haemoglobin and the number of metastatic organ site]. This evidence concerns the gene MUC16 and neoplasm.